HSI Jumps 232 Points at Market Open; INNOVENT BIO Surges Nearly 2%; LEAPMOTOR Rises Over 3% as Part of HSTECH
Market Opening Performance: The HSI opened 232 points higher at 25,452, with the HSCEI and HSTECH also showing gains of 71 points and 61 points, respectively.
Quarterly Review Results: INNOVENT BIO was added to the HSI, opening 1.9% higher, while CHINAHONGQIAO and YUM CHINA were added to the HSCEI, opening 1% and 0.3% higher, respectively.
Tech Stocks Movement: LEAPMOTOR, added to the HSTECH, opened 3.2% higher, while ASMPT was removed and opened 1.7% lower; major tech stocks like BABA, TENCENT, and NTES also saw positive openings.
Short Selling Data: Various stocks experienced significant short selling, with ratios ranging from 5.368% to 37.286%, indicating varying levels of investor sentiment across different sectors.
Trade with 70% Backtested Accuracy
Analyst Views on 00522
About the author
BofAS Increases Price Target for ASMPT (00522.HK) to HKD160, Maintains Buy Rating
Optimistic Earnings Guidance: ASMPT's management provided positive growth prospects during the 4Q25 earnings call, targeting a 35-40% market share in TCB equipment, supported by its strong position in the logic and HBM sectors.
Restructuring Focus: A restructuring plan was discussed to emphasize advanced packaging and TCB, although no specific timeline was provided for its implementation.
Brokerage Upgrades: Macquarie raised ASMPT's target price from HKD150 to HKD160, citing expected growth in AI-powered structural advancements and reaffirming a Buy rating.
Short Selling Activity: ASMPT experienced short selling of $27.70M with a ratio of 7.194%, indicating some market skepticism despite the positive outlook.
CLSA Raises ASMPT's Target Price to HKD130.7, Maintains Outperform Rating
Financial Performance: ASMPT reported an adjusted net profit of HKD181 million for 4Q25, with revenue guidance for 1QFY26 exceeding expectations and order growth projected at 40% YoY and 20% QoQ.
Market Forecast: The company has increased its total addressable market forecast for thermal compression bonding to USD1.6 billion by 2028, aiming to maintain a market share of 35-40%.
Analyst Ratings: Citi has reiterated a Buy rating on ASMPT and raised its target price to HKD145, while CLSA has increased its target price from HKD95 to HKD130.7, maintaining an Outperform rating.
Growth Drivers: The growth of ASMPT's mainstream business is significantly influenced by the expansion of AI technologies.
JPM Raises ASMPT (00522.HK) Price Target to $130, Maintains Overweight Rating
Company Performance: ASMPT (00522.HK) saw a stock increase of 6.296%, attributed to anticipated growth in advanced packaging equipment and recovery in semiconductor solutions, according to JPMorgan's report.
Operational Management: The company is focusing on stricter operational expense management to improve operational leverage in upcoming quarters.
Analyst Ratings: Macquarie has raised ASMPT's target price from $125 to $130, maintaining an Overweight rating due to expected AI-driven growth.
Market Activity: Short selling activity for ASMPT reached $27.70 million, with a short selling ratio of 7.194%.
Citi Maintains Buy Rating on ASMPT, Increases Target Price to HKD145
4Q25 Results: ASMPT's 4Q25 results exceeded both guidance and market expectations, as reported by Citi.
1Q26 Guidance: The company anticipates better-than-expected revenue for 1Q26, driven by growth in hot bar soldering and high-end die bonding machines, with improved order visibility for 1H26.
Market Position: Citi believes ASMPT's technological leadership will enable it to capture growth in the hot bar soldering market and increase its market share.
Target Price Update: ASMPT's target price has been raised from HKD125 to HKD145, with a Buy rating reiterated by Citi.
<Research>BOCI: ASMPT (00522.HK) Exceeds Quarterly Expectations; Price Target Raised to $133
Strong 4Q25 Performance: ASMPT reported impressive 4Q25 results, exceeding expectations due to high demand in AIDC and a one-time gain from selling its subsidiary AAMI, despite some margin limitations from an unfavorable product mix.
Positive Outlook for 1Q26: Management provided strong guidance for 1Q26, indicating sustained demand in AI-HBM and CoWoS-TCB, with expectations for increased orders, revenue, and SEMI gross profit margin through 2028.
Significant Increase in NP: ASMPT's net profit for 2025 surged 1.6 times to HKD902 million, leading to a total final and special dividend of HKD1.13.
Upgraded Target Price: BOCI maintained a Buy rating on ASMPT and raised its target price from $98 to $133, reflecting confidence in the company's growth prospects.
Macquarie Raises ASMPT (00522.HK) Price Target to $140 Due to AI-Driven Structural Growth
ASMPT's TCB TAM Forecast: ASMPT's management has increased its Total Addressable Market (TAM) forecast for TCB to US$1.6 billion by 2028, indicating a compound annual growth rate (CAGR) of 30% from US$759 million in 2025, surpassing the previous estimate of US$1 billion by 2027.
Impact of AI Investments: The revised TAM reflects a significant increase in investments in AI logic and high bandwidth memory (HBM), driving growth in the semiconductor industry.
Earnings Forecast Adjustments: Macquarie has raised its earnings forecasts for ASMPT for 2026, 2027, and 2028 by 6%, 6%, and 3% respectively, due to strong revenue growth in the SEMI business, although this is partially offset by a downturn in the SMT business.
Broker Rating and Target Price: Macquarie has rated ASMPT as Outperform and increased its target price by 5% to $140, reflecting confidence in the company's growth prospects.
BofAS Increases Price Target for ASMPT (00522.HK) to HKD160, Maintains Buy Rating
Optimistic Earnings Guidance: ASMPT's management provided positive growth prospects during the 4Q25 earnings call, targeting a 35-40% market share in TCB equipment, supported by its strong position in the logic and HBM sectors.
Restructuring Focus: A restructuring plan was discussed to emphasize advanced packaging and TCB, although no specific timeline was provided for its implementation.
Brokerage Upgrades: Macquarie raised ASMPT's target price from HKD150 to HKD160, citing expected growth in AI-powered structural advancements and reaffirming a Buy rating.
Short Selling Activity: ASMPT experienced short selling of $27.70M with a ratio of 7.194%, indicating some market skepticism despite the positive outlook.
CLSA Raises ASMPT's Target Price to HKD130.7, Maintains Outperform Rating
Financial Performance: ASMPT reported an adjusted net profit of HKD181 million for 4Q25, with revenue guidance for 1QFY26 exceeding expectations and order growth projected at 40% YoY and 20% QoQ.
Market Forecast: The company has increased its total addressable market forecast for thermal compression bonding to USD1.6 billion by 2028, aiming to maintain a market share of 35-40%.
Analyst Ratings: Citi has reiterated a Buy rating on ASMPT and raised its target price to HKD145, while CLSA has increased its target price from HKD95 to HKD130.7, maintaining an Outperform rating.
Growth Drivers: The growth of ASMPT's mainstream business is significantly influenced by the expansion of AI technologies.
JPM Raises ASMPT (00522.HK) Price Target to $130, Maintains Overweight Rating
Company Performance: ASMPT (00522.HK) saw a stock increase of 6.296%, attributed to anticipated growth in advanced packaging equipment and recovery in semiconductor solutions, according to JPMorgan's report.
Operational Management: The company is focusing on stricter operational expense management to improve operational leverage in upcoming quarters.
Analyst Ratings: Macquarie has raised ASMPT's target price from $125 to $130, maintaining an Overweight rating due to expected AI-driven growth.
Market Activity: Short selling activity for ASMPT reached $27.70 million, with a short selling ratio of 7.194%.
Citi Maintains Buy Rating on ASMPT, Increases Target Price to HKD145
4Q25 Results: ASMPT's 4Q25 results exceeded both guidance and market expectations, as reported by Citi.
1Q26 Guidance: The company anticipates better-than-expected revenue for 1Q26, driven by growth in hot bar soldering and high-end die bonding machines, with improved order visibility for 1H26.
Market Position: Citi believes ASMPT's technological leadership will enable it to capture growth in the hot bar soldering market and increase its market share.
Target Price Update: ASMPT's target price has been raised from HKD125 to HKD145, with a Buy rating reiterated by Citi.
<Research>BOCI: ASMPT (00522.HK) Exceeds Quarterly Expectations; Price Target Raised to $133
Strong 4Q25 Performance: ASMPT reported impressive 4Q25 results, exceeding expectations due to high demand in AIDC and a one-time gain from selling its subsidiary AAMI, despite some margin limitations from an unfavorable product mix.
Positive Outlook for 1Q26: Management provided strong guidance for 1Q26, indicating sustained demand in AI-HBM and CoWoS-TCB, with expectations for increased orders, revenue, and SEMI gross profit margin through 2028.
Significant Increase in NP: ASMPT's net profit for 2025 surged 1.6 times to HKD902 million, leading to a total final and special dividend of HKD1.13.
Upgraded Target Price: BOCI maintained a Buy rating on ASMPT and raised its target price from $98 to $133, reflecting confidence in the company's growth prospects.
Macquarie Raises ASMPT (00522.HK) Price Target to $140 Due to AI-Driven Structural Growth
ASMPT's TCB TAM Forecast: ASMPT's management has increased its Total Addressable Market (TAM) forecast for TCB to US$1.6 billion by 2028, indicating a compound annual growth rate (CAGR) of 30% from US$759 million in 2025, surpassing the previous estimate of US$1 billion by 2027.
Impact of AI Investments: The revised TAM reflects a significant increase in investments in AI logic and high bandwidth memory (HBM), driving growth in the semiconductor industry.
Earnings Forecast Adjustments: Macquarie has raised its earnings forecasts for ASMPT for 2026, 2027, and 2028 by 6%, 6%, and 3% respectively, due to strong revenue growth in the SEMI business, although this is partially offset by a downturn in the SMT business.
Broker Rating and Target Price: Macquarie has rated ASMPT as Outperform and increased its target price by 5% to $140, reflecting confidence in the company's growth prospects.
